Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Boston, MA
SEC filing record 1 source field available
Fiscal year end
31 December
AVEO PHARMACEUTICALS, INC. has filed 1,019 SEC EDGAR filings since 27 Apr 2005

SEC filing history

Showing 201-225 of 1,000 matching filings.

Per page
25
Current page
9
8-K File 001-34655

8-K

Filing date
01 Aug 2019
Reporting date
01 Aug 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4/A

FORM 4/A SUBMISSION

Filing date
14 Jun 2019
Reporting date
12 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jun 2019
Reporting date
12 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jun 2019
Reporting date
12 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
13 Jun 2019
Reporting date
12 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34655

8-K

Filing date
13 Jun 2019
Reporting date
12 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-34655

DEFA14A

Filing date
31 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-85745

SC 13G/A filing

Filing date
10 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-34655

8-K

Filing date
09 May 2019
Reporting date
09 May 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-34655

CT ORDER filing

Filing date
01 May 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
10-K/A File 001-34655

10-K/A

Filing date
30 Apr 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
DEFA14A File 001-34655

DEFA14A

Filing date
30 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
DEF 14A File 001-34655

DEF 14A

Filing date
30 Apr 2019
Reporting date
12 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
PRE 14A File 001-34655

PRE 14A

Filing date
19 Apr 2019
Reporting date
12 Jun 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13D/A File 005-85745

GROWTH EQUITY OPPORTUNITIES FUND IV, LLC - AVEO PHARMACEUTICALS, INC. -- SCHEDUL

Filing date
17 Apr 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2019
Reporting date
08 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2019
Reporting date
08 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2019
Reporting date
08 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2019
Reporting date
08 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2019
Reporting date
08 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2019
Reporting date
08 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2019
Reporting date
08 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2019
Reporting date
08 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4 SUBMISSION

Filing date
08 Apr 2019
Reporting date
08 Apr 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .